missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Gibco™ Human VEGF-165 Recombinant Protein
Recombinant Human Vascular Endothelial Cell Growth Factor (VEGF) is a bioactive protein intended for use in cell culture applications
392.00 CHF - 7420.00 CHF
Spezifikation
| Zur Verwendung mit (Anwendung) | Cell Culture |
|---|---|
| Molekulargewicht | 40 kDa |
| Reinigungsverfahren | Sequential Chromatography |
| Gen-Alias | VEGF |
| Proteinlänge | 165 aa |
| Produktcode | Marke | Menge | Preis | Menge & Verfügbarkeit | |||||
|---|---|---|---|---|---|---|---|---|---|
| Produktcode | Marke | Menge | Preis | Menge & Verfügbarkeit | |||||
|
10690920
|
Gibco™
PHC9394 |
10μg |
392.00 CHF
1 Stück |
Lager vorrätigLoggen Sie sich ein, um den Lagerbestand zu sehen
|
|||||
|
10101908
|
Gibco™
PHC9391 |
100μg |
1868.00 CHF
1 Stück |
Lager vorrätigLoggen Sie sich ein, um den Lagerbestand zu sehen
|
|||||
|
10111908
|
Gibco™
PHC9393 |
1mg |
7420.00 CHF
1 Stück |
Verfügbar ab: 09-05-2024
Loggen Sie sich ein, um den Lagerbestand zu sehen |
|||||
Beschreibung
Human VEGF-165 Recombinant Protein for Western Blot, IHC, ELISA, Ctrl, FN
VEGF exerts angiogenic, mitogenic and vascular permeability-enhancing activities specific for endothelial cells. VEGF has also been shown to be chemotactic for monocytes and osteoblasts.- High purity: no interference from other proteins or contaminants
- High biological activity: more results with less protein
- Proven compatibility: Gibco proteins bioassayed with Gibco media
- High Purity Recombinant Bioactive Protein: to help ensure Gibco growth factors are of the highest quality, each protein is analyzed for purity along with structural homogeneity to ensure a biologically active protein
- High Biological Activity: in-house activity testing of Gibco Recombinant Proteins includes cell proliferation, cytotoxicity, chemotaxis, calcium flux, secondary cytokine up-regulation, induction of surface antigen expression, anti-viral, and protease assays; specific activity is determined by the dose dependent proliferation of human umbilical vein cells (HUVEC)
Shipping Condition: Wet Ice.
Spezifikation
| Cell Culture | |
| Sequential Chromatography | |
| 165 aa | |
| Human | |
| Carrier-Free | |
| < 0.1 ng/μg | |
| 1.0 x 106 - 1.7 x 105 units⁄mg | |
| Growth Factors & Receptors | |
| Lyophilized | |
| Oncology, Angiogenesis, Stem Cell Research, Differentiation, Inflammation | |
| >95 % |
| 40 kDa | |
| VEGF | |
| ED50 range = 1-6 ng⁄mL | |
| Store this lyophilized preparation at 2 to 8°C. Upon reconstitution, apportion into working aliquots and store at ≤ –20°C. Avoid repeated freeze⁄thaw cycles. | |
| Proliferation of HUVECs (Human Umbilical Vein Endothelial Cells) | |
| Wet Ice | |
| Mammalian | |
| Recombinant, Ligand | |
| VEGF (Vascular Endothelial Growth Factor) | |
| Gibco™ |
For Research Use Only. Not intended for animal or human diagnostic or therapeutic use.